Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,946 | -167,211 | -130,041 | -92,238 | -47,473 |
| Depreciation Amortization | 2,971 | 11,011 | 8,126 | 5,316 | 2,542 |
| Accounts receivable | -7,688 | -3,593 | -2,930 | -2,508 | -688 |
| Accounts payable and accrued liabilities | 181 | -2,598 | -973 | -173 | -467 |
| Other Working Capital | -7,812 | 1,763 | 2,263 | -1,677 | -3,646 |
| Other Operating Activity | 13,656 | 30,562 | 20,618 | 13,309 | 7,385 |
| Operating Cash Flow | $-33,638 | $-130,066 | $-102,937 | $-77,971 | $-42,347 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,673 | 3,332 | -8,643 | 90,886 | 55,562 |
| PPE Investments | -2,745 | -14,851 | -12,166 | -6,415 | -2,389 |
| Investing Cash Flow | $23,928 | $-11,519 | $-20,809 | $84,471 | $53,173 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -44 | -166 | -124 | -82 | -41 |
| Common Stock Issued | 47 | 149,752 | 146,344 | 1,596 | 288 |
| Financing Cash Flow | $3 | $149,586 | $146,220 | $1,514 | $247 |
| Exchange Rate Effect | -8 | -215 | -164 | -139 | -57 |
| Beginning Cash Position | 48,921 | 41,135 | 41,135 | 41,135 | 41,135 |
| End Cash Position | 39,206 | 48,921 | 63,445 | 49,010 | 52,151 |
| Net Cash Flow | $-9,715 | $7,786 | $22,310 | $7,875 | $11,016 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,638 | -130,066 | -102,937 | -77,971 | -42,347 |
| Capital Expenditure | -2,745 | -14,851 | -12,166 | -6,415 | -2,389 |
| Free Cash Flow | -36,383 | -144,917 | -115,103 | -84,386 | -44,736 |